N-[11C]methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic

Psychiatry Research - Neuroimaging

Volumn 82, Issue 3, 1998, Pages 147-160

  Hagberg, Gisela ^a,b   Gefvert, Ola ^b   Bergström, Mats ^a,b   Wieselgren, Ing Marie ^a   Lindström, Leif ^b   Wiesel, Frits Axel ^a   Långstrom, Bengt ^a,b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

11C Raclopride; Dopamine receptors; N 11C Methylspiperone; Positron emission tomography; Quetiapine; Schizophrenia

Indexed keywords

3 METHYLSPIPERONE; CARBON 11; DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT; QUETIAPINE; RACLOPRIDE; 3-N-METHYLSPIPERONE; DIAGNOSTIC AGENT; DIBENZOTHIAZEPINE DERIVATIVE; DOPAMINE; DRUG DERIVATIVE; SALICYLAMIDE DERIVATIVE; SPIPERONE;

ADULT; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; DRUG RECEPTOR BINDING; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; SCHIZOPHRENIA; CEREBELLUM; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DOSE RESPONSE; METABOLISM;

ADULT; ANTIPSYCHOTIC AGENTS; CAUDATE NUCLEUS; CEREBELLUM; DIBENZOTHIAZEPINES; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; PUTAMEN; RACLOPRIDE; RECEPTORS, DOPAMINE D2; SALICYLAMIDES; SCHIZOPHRENIA; SPIPERONE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032580805     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4927(98)00020-1     Document Type: Article

References (49)

1. Andersson, J.L.R., 1995. A rapid and accurate method to realign PET scans utilizing image edge transformation. Journal of Nuclear Medicine 36, 657-669.
2. 2 receptors in the human neostriatum. Schizophrenia Bulletin 14, 471-484.
3. Bergström, M., Eriksson, L., Bohm, C., Blomqvist, G., Litton, J., 1983. Correction for scattered radiation in a ring detector positron camera by integral transformations of the projections. Journal of Computer Assisted Tomography 7, 42-50.
4. 2 receptors in the brain of several mammalians. Journal of Neural Transmission -General Section 80, 105-1127.
5. Delforges, J., Syrota, A., Bendriem, B., 1996. Concept of reaction volume in the in vivo ligand-receptor model. Journal of Nuclear Medicine 37, 118-125.
6. 2 receptor increase in PET study of schizophrenia. Archives of General Psychiatry 44, 671-672.
7. 2 receptors studied by PET - a comparison to the equilibrium analysis. Journal of Cerebral Blood Flow and Metabolism 9, 696-708.
8. 2 dopamine receptors in neuroleptic-naive schizophrenic patients. Archives of General Psychiatry 47, 213-219.
9. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Archives of General Psychiatry 49, 538-544.
10. Farde, L., 1996. The advantage of using positron emission tomography in drug research. Trends in Neuroscience 19, 211-214.
11. 3H-N-methylspiperone to dopamine and serotonin receptors. Life Sciences 40, 987-995.
12. 2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel®) in patients with schizophrenia. Psychopharmacology 135, 119-126.
13. 2 receptor occupancy of quetiapine (Seroquel) in patients with schizophrenia, manuscript.
14. Goyer, P.F., Berridge, M.S., Morris, E.D., Semple, W.E., Compton-Toth, B.A., Schultz, S.C., Wong, D.F., Mirald, F., Meltzer, H.Y., 1996. PET measurements of neuroreceptor occupancy by typical and atypical neuroleptics. Journal of Nuclear Medicine 37, 1122-1127.
15. 2 dopamine receptors in the monkey brain. Synapse 25, 321-325.
16. 11C-raclopride PET and reference region methods. Proceedings of Neuroreceptor Mapping, Neuroimage supplement, p. 20.
17. 11C-raclopride PET. (Abstract) Schizophrenia Research 29, 165-166.
18. 3H]-raclopride to rat and human brain membranes. Journal of Neurochemistry 55, 2048-2057.
19. 2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study. European Neuropsychopharmacology 5, 19-25.
20. Holte, S., Eriksson, L., Dahlbom, M., 1989. A preliminary evaluation of the Scanditronix PC2048-15B brain scanner. European Journal of Nuclear Medicine 15, 719-721.
21. Hulme, E.C., Birdsall, N.J.M., 1992. Strategy and tactics in receptor-binding studies. In: Hulme, E.G. (Ed.), Receptor-ligand Interactions. A Practical Approach. IRL Press at Oxford University Press, Oxford, New York, Tokyo, pp. 63-176
22. Hume, S.P., Myers, R., Bloomfield, P.M., Opacka-Juffry, J., Cremer, J.E., Ahier, R.G., Luthra, S.K., Brooks, D.J., Lammertsma, A.A., 1992. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse 12, 47-54.
23. 3H]raclopride in reserpine treated mouse brain. Journal of Neural Transmission -General Section 85, 1-10.
24. 3H]N-methylspiperone. Neuropharmacology 30, 1101-1106.
25. 2 dopamine receptor binding differences of clozapine and haloperidol. Journal of Neural Transmission - General Section 86, 163-173.
26. 11C raclopride studies. Journal of Cerebral Blood Flow and Metabolism 16, 42-52.
27. Lammertsma, A.A., Hume, S.P., 1996. Simplified reference tissue model for PET receptor studies. Neuroimage 4, 153-158.
28. 18F]-N-methylspiroperidol binding in the basal ganglia: comparison of simulations and experimental results from PET studies in baboons. Synapse 9, 195-207.
29. 11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. Journal of Cerebral Blood Flow and Metabolism 14, 995-1010.
30. Logan, J., Fowler, J.S., Volkow, N.D., Wang, G.J., Ding, Y.S., Alexoff, D.L., 1996. Distribution volume ratios without blood sampling from graphical analysis of PET data. Journal of Cerebral Blood Flow and Metabolism 16, 834-840.
31. 11C]Af-methylspiperone. Psychiatry Research: Neuroimaging 61, 67-83.
32. 2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. American Journal of Psychiatry 152, 1444-1449.
33. Patlak, C.S., Blasberg, R.G., 1985. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. Journal of Cerebral Blood Flow and Metabolism 5, 584-590.
34. Pazos, A., Probst, A., Palacios, J., 1987. Serotonin receptors in the human brain. IV: Autoradiographic mapping of serotonin-2-receptors. Neuroscience 21, 123-139.
35. 4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs. Psychopharmacology 120, 365-368.
36. Saller, C.F., Salama, A.I., 1993. Seroquel: biochemical profile of a potential atypical antipsychotic. Psychopharmacology 112, 285-292.
37. Schotte, A., Janssen, P.F.M., Gommeren, W., Luyten, W.H.M.L., VanGompel, P., Lesage, A.S., De Loore, K., Leysen, J.E., 1996. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology 124, 57-73.
38. 2 receptor reveals different densities of dopamine receptor antagonist ligands. Implications for human brain positron emission tomography. European Journal of Pharmacology 227, 139-146.
39. Seeman, P., Guan, H., Van Tol, H.H.M., 1993. Dopamine D4 receptors are elevated in schizophrenia. Nature 365, 441-445.
40. Seeman, P., Kapur, S., 1997. Clozapine occupies high levels of dopamine D2 receptors. Life Science 60(12), 207-216.
41. 4 receptors. Neuropsychopharmacology 16, 93-110.
42. 2 receptor occupancy in schizophrenic patients. Biological Psychiatry 23, 653-663.
43. Sokoloff, P., Giros, B., Martres, M.P., Bouthenet, M.L., Schwartz, J.C., 1990. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 357, 146-151.
44. Votaw, J.R., Kessler, R.M., dePaulis, T., 1993. Failure of the three compartment model to describe the pharmacokinetics in brain of a high affinity substituted benzamide. Synapse 15, 177-190.
45. Wiesel, F.A., 1995. Positron emission tomography, receptors and schizophrenia. In: Häfner, H., Gattaz, W.F. (Eds.), Search for the Causes of Schizophrenia, vol. III. Springer, Berlin, Heidelberg, New York, pp. 252-262.
46. Wolkin, A., Brodie, J.D., Rotrosen, J., 1989. Dopamine receptor occupancy and plasma haloperidol levels. Archives of General Psychiatry 46, 482-483.
47. Wong, D.F., Wagner, H.N., Tune, L.E., Dannals, R.F., Links, J.M., Frost, J.J., Ravert, H.T., Wilson, A.A., Rosenbaum, A.E., Gjedde, A., Douglas, K.H., Petronis, J.D., Folstein, M.F., Toung, J.K.T., Burns, H.D., Kuhar, M.J., 1984. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science 226, 1393-1396.
48. Wong, D.F., Wagner, H.N., Tune, L.E., Dannals, R.F., Pearlson, G.D., Links, J.M., Tamminga, C.A., Broussolle, E.P., Ravert, H.T., Wilson, A.A., Toung, J.K.T., Malat, J., Williams, J.A., O'Tuama, L.A., Snyder, S.H., Kuhar, M.J., Gjedde, A., 1986. Positron emission tomography reveals elevated dopamine receptors in drug-naive schizophrenics. Science 234, 1558-1563.
49. Wong, J. et al., 1995. Multiple dose pharmacokinetics of quetiapine in elderly schizophrenic patients, Annual Meeting of the American Psychiatric Association, abstract 612.